Related Experiment Video
Updated: May 19, 2026
07:33
Intralymphatic Immunotherapy and Vaccination in Mice
Published on: February 2, 2014
Subcutaneous IgG replacement after pediatric SCT.
Mikael Sundin1, Karin Nordin, Yvonne Jostemyr
1Division of Pediatrics, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden. mikael.sundin@ki.se
Pediatric Transplantation
|August 31, 2012
Summary
Subcutaneous immunoglobulin (IgG) replacement is a safe and effective alternative to intravenous IgG for children with prolonged hypogammaglobulinemia after stem cell transplantation (SCT). This method offers comparable efficacy with fewer side effects and improved treatment convenience.
Area of Science:
- Pediatric Hematology/Oncology
- Immunology
- Stem Cell Transplantation
Background:
- Hypogammaglobulinemia is a frequent complication following pediatric hematopoietic stem cell transplantation (SCT).
- Intravenous immunoglobulin (IgG) replacement is standard, but poor venous access can hinder treatment in some children.
- Subcutaneous IgG (SC IgG) replacement has proven effective for primary antibody deficiencies, improving quality of life.
Purpose of the Study:
- To compare the efficacy and safety of intravenous IgG (IV IgG) versus SC IgG replacement in children with prolonged hypogammaglobulinemia post-SCT.
- To assess patient and family acceptance of different IgG administration routes.
Main Methods:
- Retrospective analysis of 158 children undergoing SCT between 2003-2010, with 58 (37%) experiencing prolonged hypogammaglobulinemia.
- Comparison of IV IgG (n=46) and SC IgG (n=12) replacement therapy.
- Assessment of IgG levels, infection rates, side effects, and family attitudes towards treatment.
Main Results:
- No significant difference in achieving target IgG levels (≥4 g/L) between IV IgG and SC IgG groups (64-96%).
- SC IgG group showed less variability in IgG trough levels.
- Significantly fewer side effects were observed with SC IgG (16.7%) compared to IV IgG (67.4%, p=0.003).
- Clinical infection rates were similar between groups.
- Families in the SC IgG group did not desire a change in administration route.
Conclusions:
- SC IgG replacement is a convenient and safe alternative to IV IgG for pediatric SCT recipients with hypogammaglobulinemia.
- SC IgG offers comparable efficacy to IV IgG with a better safety profile and improved patient/family experience.
- SC IgG should be considered as a primary option for IgG replacement in children undergoing SCT.
Related Concept Videos
01:15Transcytosis of IgG
Transcytosis is the process in which molecules are internalized by endocytosis, transported across the cell, and released through exocytosis from the opposite end of the cell. Molecules such as insulin, immunoglobulins, and certain nutrients are transferred through the recycling endosomes by recycling and transcytosis.
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
01:22Development of Immunocompetence
The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...